Clinical Trial

Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia： Specificity and Sensitivity in Clinical Practice

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 21, 2024 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-29.
Trial Details
NCT Number NCT06533410
Lead Sponsor Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborators: Hebei Provincial Hospital of Traditional Chinese Medicine, BAODING NO.1 HOSPITAL OF TCM, Inner Mongolia Hospital of Traditional Chinese Medicine, Shenzhen Hospital of Traditional Chinese Medicine, Suzhou Hospital of Traditional Chinese Medicine
Conditions Fibromyalgia
Enrollment 59 participants
Start Date 2024-05-21
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-21